• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Prophylaxis Against COVID-19 With Hydroxychloroquine and Chloroquine: Comment on the Article by Putman et al.使用羟氯喹和氯喹预防新型冠状病毒肺炎：对普特曼等人文章的评论
Arthritis Rheumatol. 2021 Sep;73(9):1765-1767. doi: 10.1002/art.41742. Epub 2021 Jul 31.
2
Ototoxicity prevention during the SARS-CoV-2 (COVID-19) emergency.在 SARS-CoV-2（COVID-19）紧急情况下预防耳毒性。
J Glob Antimicrob Resist. 2020 Dec;23:263-264. doi: 10.1016/j.jgar.2020.09.030. Epub 2020 Oct 17.
3
Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review.羟氯喹或氯喹治疗或预防 COVID-19：一项实时系统评价。
Ann Intern Med. 2020 Aug 18;173(4):287-296. doi: 10.7326/M20-2496. Epub 2020 May 27.
4
Chloroquine and Hydroxychloroquine in COVID-19: Practice Implications for Healthcare Professionals.氯喹和羟氯喹在2019冠状病毒病中的应用：对医疗保健专业人员的实践启示
J Coll Physicians Surg Pak. 2020 Oct;30(10):124-128. doi: 10.29271/jcpsp.2020.supp2.124.
5
Reply Letter - Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19.回复信 - 氯喹和羟氯喹治疗2019冠状病毒病的疗效
Eur Rev Med Pharmacol Sci. 2021 Jul;25(13):4445. doi: 10.26355/eurrev_202107_26232.
6
Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story.氯喹和羟氯喹治疗 COVID-19：一个永无止境的故事。
Appl Microbiol Biotechnol. 2021 Feb;105(4):1333-1343. doi: 10.1007/s00253-021-11094-4. Epub 2021 Jan 30.
7
Letter to editor on the paper entitled "Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19".致编辑的信：关于题为“氯喹和羟氯喹治疗COVID-19的疗效”的论文
Eur Rev Med Pharmacol Sci. 2021 Jul;25(13):4446-4447. doi: 10.26355/eurrev_202107_26233.
8
Reply to the Letter to Editor by Lacout and colleagues: Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: a Systematic Review and Meta-analysis.对拉库特及其同事致编辑信的回复：氯喹和羟氯喹用于治疗2019冠状病毒病：一项系统评价和荟萃分析
J Gen Intern Med. 2021 Aug;36(8):2468-2469. doi: 10.1007/s11606-021-06722-8. Epub 2021 Apr 26.
9
Letter to the editor: The effect of hydroxychloroquine on COVID-19.致编辑的信：羟氯喹对新型冠状病毒肺炎的影响
J Infect Public Health. 2022 Jan;15(1):68. doi: 10.1016/j.jiph.2021.12.006. Epub 2021 Dec 10.
10
What makes (hydroxy)chloroquine ineffective against COVID-19: insights from cell biology.（羟）氯喹对抗 COVID-19 无效的原因：细胞生物学的见解。
J Mol Cell Biol. 2021 Jul 6;13(3):175-184. doi: 10.1093/jmcb/mjab016.

本文引用的文献

1
A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19.羟氯喹预防 COVID-19 的集群随机试验。
N Engl J Med. 2021 Feb 4;384(5):417-427. doi: 10.1056/NEJMoa2021801. Epub 2020 Nov 24.
2
Post-exposure prophylaxis with hydroxychloroquine for the prevention of COVID-19, a myth or a reality? The PEP-CQ Study.羟氯喹用于 COVID-19 的暴露后预防，是神话还是现实？PEP-CQ 研究。
Int J Antimicrob Agents. 2020 Dec;56(6):106224. doi: 10.1016/j.ijantimicag.2020.106224. Epub 2020 Nov 6.
3
Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial.羟氯喹作为医护人员 2019 冠状病毒病（COVID-19）的暴露前预防：一项随机试验。
Clin Infect Dis. 2021 Jun 1;72(11):e835-e843. doi: 10.1093/cid/ciaa1571.
4
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial.羟氯喹与安慰剂对医护人员暴露前预防新型冠状病毒的疗效和安全性：一项随机临床试验
JAMA Intern Med. 2021 Feb 1;181(2):195-202. doi: 10.1001/jamainternmed.2020.6319.
5
Moving fast but going slow: coordination challenges for trials of COVID-19 post-exposure prophylaxis.快速行动但进展缓慢：COVID-19 暴露后预防试验的协调挑战。
Trials. 2020 Sep 29;21(1):815. doi: 10.1186/s13063-020-04754-9.
6
Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern Italy.抗疟药物治疗患者对 COVID-19 的易感性：意大利北部艾米利亚-罗马涅地区的一项基于人群的研究。
Arthritis Rheumatol. 2021 Jan;73(1):48-52. doi: 10.1002/art.41475. Epub 2020 Nov 27.
7
Antirheumatic Disease Therapies for the Treatment of COVID-19: A Systematic Review and Meta-Analysis.抗风湿疾病疗法治疗 COVID-19：系统评价和荟萃分析。
Arthritis Rheumatol. 2021 Jan;73(1):36-47. doi: 10.1002/art.41469. Epub 2020 Nov 19.
8
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.羟氯喹作为 COVID-19 暴露后预防的随机试验。
N Engl J Med. 2020 Aug 6;383(6):517-525. doi: 10.1056/NEJMoa2016638. Epub 2020 Jun 3.
9
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.瑞德西韦和氯喹在体外能有效抑制新出现的新型冠状病毒（2019 - 新冠病毒）。
Cell Res. 2020 Mar;30(3):269-271. doi: 10.1038/s41422-020-0282-0. Epub 2020 Feb 4.

Prophylaxis Against COVID-19 With Hydroxychloroquine and Chloroquine: Comment on the Article by Putman et al.

作者信息

Tang Wei, Gartshteyn Yevgeniya, Guo Cathy, Chen Tommy, Giles Jon, Askanase Anca

机构信息

New York-Presbyterian Hospital and Columbia University Medical Center, New York, NY.

出版信息

Arthritis Rheumatol. 2021 Sep;73(9):1765-1767. doi: 10.1002/art.41742. Epub 2021 Jul 31.

DOI:10.1002/art.41742
PMID:33779073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8251418/
Abstract
摘要